99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer

Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208 Boorjian, 2011, Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence, Eur Urol, 59, 893, 10.1016/j.eururo.2011.02.026 Eder, 2012, 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging, Bioconjug Chem, 23, 688, 10.1021/bc200279b Maurer, 2016, Current use of PSMA-PET in prostate cancer management, Nat Rev Urol, 13, 226, 10.1038/nrurol.2016.26 Afshar-Oromieh, 2015, The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer, Eur J Nucl Med Mol Imaging, 42, 197, 10.1007/s00259-014-2949-6 Eiber, 2015, Evaluation of hybrid (6)(8)Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy, J Nucl Med, 56, 668, 10.2967/jnumed.115.154153 Perera, 2016, Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis, Eur Urol, 70, 926, 10.1016/j.eururo.2016.06.021 Rauscher, 2018, Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen-ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy, Eur Urol, 73, 656, 10.1016/j.eururo.2018.01.006 Guideline, 2017 Schottelius, 2015, [(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery, EJNMMI Res, 5, 68, 10.1186/s13550-015-0147-6 Robu, 2017, Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer, J Nucl Med, 58, 235, 10.2967/jnumed.116.178939 Maurer, 2015, Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer, Eur Urol, 68, 530, 10.1016/j.eururo.2015.04.034 Rauscher, 2017, Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up, BJU Int, 120, 40, 10.1111/bju.13713 Benz, 1991, Monoclonal antibody BW431/26 labelled with technetium 99m and indium 111: an investigation of the biodistribution and the dosimetry in patients, Eur J Nucl Med, 18, 813, 10.1007/BF00175060 Bunschoten, 2016, Tracers applied in radioguided surgery Genders, 2012, Methods for calculating sensitivity and specificity of clustered data: a tutorial, Radiology, 265, 910, 10.1148/radiol.12120509 Jilg, 2017, Diagnostic accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before salvage lymph node dissection for recurrent prostate cancer, Theranostics, 7, 1770, 10.7150/thno.18421 Suardi, 2015, Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years, Eur Urol, 67, 299, 10.1016/j.eururo.2014.02.011 Rauscher, 2016, Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy, J Nucl Med, 57, 1713, 10.2967/jnumed.116.173492 Bandini, 2017, Salvage surgery for nodal recurrent prostate cancer, Curr Opin Urol, 27, 604, 10.1097/MOU.0000000000000437 Rauscher, 2016, Intrapatient comparison of 111In-PSMA I&T SPECT/CT and hybrid 68Ga-HBED-CC PSMA PET in patients with early recurrent prostate cancer, Clin Nucl Med, 41, e397, 10.1097/RLU.0000000000001273 van der Poel, 2017, Sentinel node biopsy for prostate cancer: report from a consensus panel meeting, BJU Int, 120, 204, 10.1111/bju.13810 van Oosterom, 2016, Revolutionizing (robot-assisted) laparoscopic gamma tracing using a drop-in gamma probe technology, Am J Nucl Med Mol Imaging, 6, 1 Baranski AC, Schafer M, Bauder-Wust U, et al. PSMA-11 derived dual-labeled PSMA-inhibitors for preoperative PET imaging and precise fluorescence-guided surgery of prostate cancer. J Nucl Med. In press. doi:10.2967/jnumed.117.201293. Banerjee, 2017, (111)In- and IRDye800CW-labeled PLA-PEG nanoparticle for imaging prostate-specific membrane antigen-expressing tissues, Biomacromolecules, 18, 201, 10.1021/acs.biomac.6b01485 Neuman, 2015, Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer, Clin Cancer Res, 21, 771, 10.1158/1078-0432.CCR-14-0891